Sort
11,323 grants matching “glioblastoma”
Applying Molecular and Functional Genomics to Identify Biomarkers for Diagnosing and Treating Cancer
$138,169Kiranmai Gumireddy · Wistar Institute · R50 · FY2020 · CA
DEVELOPMENT OF GSTP1-TARGETED ANTI-GLIOMA THERAPEUTICS
$138,141Duke University · P50 · FY2004 · CA
DEVELOPMENT OF GSTP1-TARGETED ANTI-GLIOMA THERAPEUTICS
$138,002Duke University · P50 · FY2005 · CA
Control mechanisms of 5-hydroxymethylcytosine metabolism in human cells
$138,000Haeyoung Kim · Texas A&M University-Kingsville · R16 · FY2024 · GM
Control mechanisms of 5-hydroxymethylcytosine metabolism in human cells
$138,000Haeyoung Kim · Texas A&M University-Kingsville · R16 · FY2025 · GM
Control mechanisms of 5-hydroxymethylcytosine metabolism in human cells
$138,000Haeyoung Kim · Texas A&M University-Kingsville · R16 · FY2023 · GM
DEVELOPMENT OF GSTP1-TARGETED ANTI-GLIOMA THERAPEUTICS
$137,998Francis Ali-Osman · Duke University · P50 · FY2006 · CA
BMP4 Engineered Mesenchymal Stem Cell Therapy for Glioblastoma
$137,964Alfredo Quinones-Hinojosa · Johns Hopkins University · R01 · FY2016 · CA
Core 1: Microfabication
$137,635Rong Fan · Yale University · U54 · FY2016 · CA
Development of Mouse Astrocytoma Model for Preclinical Testing
$137,487Karlyne M Reilly · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Therapeutic approaches that target cancer cell metabolism
$137,295Ravi K Amaravadi · University Of Pennsylvania · K23 · FY2009 · CA
Therapeutic approaches that target cancer cell metabolism
$137,295Ravi K Amaravadi · University Of Pennsylvania · K23 · FY2011 · CA
Therapeutic approaches that target cancer cell metabolism
$137,295Ravi K Amaravadi · University Of Pennsylvania · K23 · FY2008 · CA
Therapeutic approaches that target cancer cell metabolism
$137,295Ravi K Amaravadi · University Of Pennsylvania · K23 · FY2012 · CA
Therapeutic approaches that target cancer cell metabolism
$137,295Ravi K Amaravadi · University Of Pennsylvania · K23 · FY2010 · CA
Gene Therapy and the Brain: Neuroimmune Interactions
$136,912Pedro R Lowenstein · Cedars-Sinai Medical Center · R01 · FY2011 · NS
EGFR signaling and normal and tumor-derived neural stem cell behavior
$136,890John A Boockvar · Weill Medical Coll Of Cornell Univ · K08 · FY2011 · CA
EGFR signaling and normal and tumor-derived neural stem cell behavior
$136,890John A Boockvar · Weill Medical Coll Of Cornell Univ · K08 · FY2009 · CA
EGFR signaling and normal and tumor-derived neural stem cell behavior
$136,890John A Boockvar · Weill Medical Coll Of Cornell Univ · K08 · FY2012 · CA
EGFR signaling and normal and tumor-derived neural stem cell behavior
$136,890John A Boockvar · Weill Medical Coll Of Cornell Univ · K08 · FY2008 · CA
EGFR signaling and normal and tumor-derived neural stem cell behavior
$136,890John A Boockvar · Weill Medical Coll Of Cornell Univ · K08 · FY2010 · CA
Targeted MV-CEA as a Potent Antitumor Agent against GBM
$136,719Mayo Clinic · P50 · FY2004 · CA
Imaging IDH1 Mutations in Glioma and Other Malignancies
$136,590Satish K. Chitneni · Duke University · R21 · FY2014 · CA
Malignant Gliomas Biorepository Core
$136,565Ichiro Nakano · Ohio State University · P01 · FY2015 · CA
Genome-wide promoter methylation profiling of glioma
$136,500Albert Lai · University Of California Los Angeles · K08 · FY2012 · CA